Date Issued
|
Report Number
18-00777-224
No. 1
to Veterans Health Administration (VHA)
Closure Date: 8/26/2020
The Corporal Michael J. Crescenz VA Medical Center Director ensures that providers understand the importance of monitoring for cardiac changes, drug-drug interactions, and signs of oversedation when initiating patients on methadone.
No. 2
to Veterans Health Administration (VHA)
Closure Date: 8/26/2020
The Corporal Michael J. Crescenz VA Medical Center Director monitors that providers and clinical staff effectively and directly communicate with one another when providing complex patient care.
No. 3
to Veterans Health Administration (VHA)
Closure Date: 2/3/2020
The Corporal Michael J. Crescenz VA Medical Center Director confirms that the issue brief submitted on the identified patient contains accurate information.
No. 4
to Veterans Health Administration (VHA)
Closure Date: 2/3/2020
The Corporal Michael J. Crescenz VA Medical Center Director reviews the root cause analysis related to the identified patient to determine if the team composition compromised the integrity of the root cause analysis and take appropriate action if necessary.
No. 5
to Veterans Health Administration (VHA)
Closure Date: 5/11/2020
The Corporal Michael J. Crescenz VA Medical Center Director ensures that root cause analysis team compositions include appropriate staff and monitor compliance.
No. 6
to Veterans Health Administration (VHA)
Closure Date: 2/3/2020
The Corporal Michael J. Crescenz VA Medical Center Director considers Peer Review for Quality Management for the additional two providers identified in this report.
No. 7
to Veterans Health Administration (VHA)
Closure Date: 5/11/2020
The Corporal Michael J. Crescenz VA Medical Center Director ensures that Unit 7E staff are knowledgeable of the observation policy, and nursing leaders are monitoring staff compliance when assigned rounding responsibilities.
No. 8
to Veterans Health Administration (VHA)
Closure Date: 8/26/2020
The Corporal Michael J. Crescenz VA Medical Center Director completes actions initiated or taken to resolve identified deficiencies that contributed to the events discussed in this report, and monitors for compliance.
No. 9
to Veterans Health Administration (VHA)
Closure Date: 8/26/2020
The Corporal Michael J. Crescenz VA Medical Center Director certifies that providers receive ongoing education on the required elements of a signed written consent prior to the initiation of methadone and ensures that providers comply with VA policy and monitors for compliance.